These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7058458)
1. Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype. Berger GM; Van der Westhuyzen JH; Huskisson J; Bonnici F; Henderson HE S Afr Med J; 1982 Feb; 61(8):266-72. PubMed ID: 7058458 [TBL] [Abstract][Full Text] [Related]
2. Why very low density lipoprotein levels are normal in familial hyperchylomicronaemia. Berger GM Atherosclerosis; 1979 Sep; 34(1):83-6. PubMed ID: 227432 [TBL] [Abstract][Full Text] [Related]
3. Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase. Rubinstein A; Gibson JC; Paterniti JR; Kakis G; Little A; Ginsberg HN; Brown WV J Clin Invest; 1985 Feb; 75(2):710-21. PubMed ID: 3973025 [TBL] [Abstract][Full Text] [Related]
4. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man. Brunzell JD; Hazzard WR; Porte D; Bierman EL J Clin Invest; 1973 Jul; 52(7):1578-85. PubMed ID: 4352459 [TBL] [Abstract][Full Text] [Related]
5. Modifications of plasma lipoproteins after lipase activation in patients with chylomicronemia. Manzato E; Zambon S; Marin R; Baggio G; Crepaldi G J Lipid Res; 1986 Dec; 27(12):1248-58. PubMed ID: 3559389 [TBL] [Abstract][Full Text] [Related]
7. Familial lipoprotein lipase and apolipoprotein C-II deficiency. Lipoprotein and apoprotein analysis, adipose tissue and hepatic lipoprotein lipase levels in seven patients and their first degree relatives. Fellin R; Baggio G; Poli A; Augustin J; Baiocchi MR; Baldo G; Sinigaglia M; Greten H; Crepaldi G Atherosclerosis; 1983 Oct; 49(1):55-68. PubMed ID: 6651913 [TBL] [Abstract][Full Text] [Related]
8. Familial hyperchylomicronaemia in four families. Problems in diagnosis, management, and aetiology reviewed. Berger GM; Bonnici F S Afr Med J; 1977 Apr; 51(18):623-8. PubMed ID: 867182 [TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of type I hyperlipoproteinemia. Gnasso A; Koch H; Haberbosch W; Fellin R; Postiglione A; Augustin J Monogr Atheroscler; 1986; 14():135-9. PubMed ID: 3736552 [No Abstract] [Full Text] [Related]
10. Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transfer. Liu G; Excoffon KJ; Wilson JE; McManus BM; Miao L; Benoit P; Duverger N; Branellec D; Denefle P; Hayden MR; Lewis ME Clin Invest Med; 1998; 21(4-5):172-85. PubMed ID: 9800066 [TBL] [Abstract][Full Text] [Related]
11. [Pathologic decrease in lipoprotein lipase activity in relation to the development of hyperlipemias and their significance for coronary heart disease]. Breier C Wien Klin Wochenschr Suppl; 1986; 167():1-16. PubMed ID: 3458343 [TBL] [Abstract][Full Text] [Related]
12. The plasma lipoproteins in familial chylomicronemia. Analysis by zonal ultracentrifugation. Manzato E; Marin R; Gasparotto A; Baggio G; Fellin R; Crepaldi G J Lab Clin Med; 1984 Nov; 104(5):778-88. PubMed ID: 6491471 [TBL] [Abstract][Full Text] [Related]
13. Clearance defects in primary chylomicronemia: a study of tissue lipoprotein lipase activities. Berger GM Metabolism; 1986 Nov; 35(11):1054-61. PubMed ID: 3773723 [TBL] [Abstract][Full Text] [Related]
14. The lipid-lowering effect of dietary proanthocyanidins in rats involves both chylomicron-rich and VLDL-rich fractions. Quesada H; Díaz S; Pajuelo D; Fernández-Iglesias A; Garcia-Vallvé S; Pujadas G; Salvadó MJ; Arola L; Bladé C Br J Nutr; 2012 Jul; 108(2):208-17. PubMed ID: 22011563 [TBL] [Abstract][Full Text] [Related]
15. Studies of a variant very-low-density lipoprotein with an acquired deficiency of apolipoprotein C-II. Reckless JP; Stocks J; Holdsworth G; Galton DJ; Suggett AJ; Walton KW Clin Sci (Lond); 1982 Jan; 62(1):93-100. PubMed ID: 7056035 [TBL] [Abstract][Full Text] [Related]
16. Chylomicronaemia in multiple myeloma. Aviram M; Carter A; Brook JG; Tatarsky I Scand J Haematol; 1985 May; 34(5):436-41. PubMed ID: 4012223 [TBL] [Abstract][Full Text] [Related]
17. Influence of lipolysis on chylomicron clearance and HDL cholesterol levels. Patsch J Eur Heart J; 1998 Jul; 19 Suppl H():H2-6. PubMed ID: 9717057 [TBL] [Abstract][Full Text] [Related]
18. The clinical, biochemical, and familial presentation of type V hyperlipoproteinemia in childhood. Kwiterovich PO; Farah JR; Brown WV; Bachorik PS; Baylin SB; Neill CA Pediatrics; 1977 Apr; 59(4):513-25. PubMed ID: 191790 [TBL] [Abstract][Full Text] [Related]
19. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516 [TBL] [Abstract][Full Text] [Related]
20. Selective protamine sulphate inactivation of lipoprotein lipase and hepatic lipase in human post-heparin plasma: specific lipase levels in normals and in type I hyperlipoproteinaemia. Berger GM; Abraham PR Clin Chim Acta; 1977 Dec; 81(3):219-28. PubMed ID: 923094 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]